Versant Vantage II GP-GP, LLC sold $10.2M of LENZ Therapeutics (LENZ)

Executed Jun 10 2025, disclosed Jun 12 2025, 2 days later.

Value, as filed

$10.2M

350,000 sh × $29.00

Executed

Jun 10 2025

the trade date, as filed

Disclosed

Jun 12 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

VL Versant Vantage II GP-GP, LLC 10% owner profile →

Versant Vantage II GP-GP, LLC (10% owner) filed 3 Form 4 reports as a reporting entity in the past 24 months (0 purchases, 3 sales), most often in LENZ Therapeutics, Inc. (LENZ). The largest single filing was $10.2M of LENZ (350,000 sh × $29.00, as filed), executed Jun 10 2025.

The name

LENZ LENZ Therapeutics, Inc. LENZ · Healthcare · 12 filings in 24 months ticker →

Healthcare · LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Versant Vantage II GP-GP, LLC in LENZ

LENZSALE LENZ Therapeutics, Inc. –
224,674 sh across 4 lots · price not plausible
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET LENZSALE LENZ Therapeutics, Inc. $6.1M
200,000 sh × $30.47
Exec Jun 27 2025
Filed Jul 1 2025 · 5:30 PM ET